Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population

被引：0

作者：

Zonglin Xie

Zhenpeng Peng

Yujian Zou

Han Xiao

Bin Li

Qian Zhou

Shuling Chen

Lixia Xu

Jingxian Shen

Yunxian Mo

Sui Peng

Ming Kuang

Jianting Long

Shi-Ting Feng

机构：

[1] The First Affiliated Hospital of Sun Yat-Sen University,Department of Gastroenterology and Hepatology

[2] the First Affiliated Hospital,Department of Radiology

[3] Sun Yat-Sen University,Department of Radiology

[4] Yuexiu Distinct,Division of Interventional Ultrasound

[5] The Affiliated Dongguan Hospital,Clinical Trial Unit

[6] Southern Medical University,Department of Liver Surgery

[7] The First Affiliated Hospital of Sun Yat-Sen University,Department of Oncology

[8] The First Affiliated Hospital of Sun Yat-Sen University,undefined

[9] The First Affiliated Hospital of Sun Yat-Sen University,undefined

[10] the First Affiliated Hospital,undefined

[11] Sun Yat-Sen University,undefined

[12] Yuexiu Distinct,undefined

[13] Department of Medical Imaging,undefined

[14] Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine,undefined

来源：

BMC Cancer | / 22卷

关键词：

Hepatocellular carcinoma; LI-RADS; Diagnosis; Low-risk; Non-invasive;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 61 条

[1]

Elsayes KM(2019)LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance J Hepatocell Carcinoma 6 649-69

[2]

Kielar AZ(2018)Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients Radiol 289 816-830

[3]

Chernyak V(2008)Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma Hepatol 47 2145-2146

[4]

Chernyak V(2017)The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015 JAMA Oncol. 3 1683-1691

[5]

Fowler KJ(2018)Electronic address e e e, European Association for the Study of the L. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma J Hepatol 69 182-236

[6]

Kamaya A(2018)Comparison of MRI Features of Epithelioid Hepatic Angiomyolipoma and Hepatocellular Carcinoma: Imaging Data From Two Centers Front Oncol 8 600-2560

[7]

Song ZZ(2018)Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging Eur Radiol 28 2549-821

[8]

Akinyemiju T(2019)Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study Aliment Pharmacol Ther 50 809-838

[9]

Abera S(2016)Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study Hepatol 63 827-1362

[10]

Liu W(2020)MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy AJR Am J Roentgenol 215 1354-601

← 1 2 3 4 5 6 7 →